JP2013536183A5 - - Google Patents

Download PDF

Info

Publication number
JP2013536183A5
JP2013536183A5 JP2013523219A JP2013523219A JP2013536183A5 JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5 JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
alkenyl
wounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013523219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013536183A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/045833 external-priority patent/WO2012016109A2/en
Publication of JP2013536183A publication Critical patent/JP2013536183A/ja
Publication of JP2013536183A5 publication Critical patent/JP2013536183A5/ja
Pending legal-status Critical Current

Links

JP2013523219A 2010-07-30 2011-07-29 皮膚修復のための化合物及び方法 Pending JP2013536183A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36923210P 2010-07-30 2010-07-30
US61/369,232 2010-07-30
US41911510P 2010-12-02 2010-12-02
US61/419,115 2010-12-02
PCT/US2011/045833 WO2012016109A2 (en) 2010-07-30 2011-07-29 Compounds and methods for skin repair

Publications (2)

Publication Number Publication Date
JP2013536183A JP2013536183A (ja) 2013-09-19
JP2013536183A5 true JP2013536183A5 (https=) 2014-09-18

Family

ID=44543791

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013523219A Pending JP2013536183A (ja) 2010-07-30 2011-07-29 皮膚修復のための化合物及び方法

Country Status (18)

Country Link
US (1) US20120136011A1 (https=)
EP (1) EP2598140B1 (https=)
JP (1) JP2013536183A (https=)
KR (1) KR20130130694A (https=)
CN (1) CN103068382A (https=)
AR (1) AR082428A1 (https=)
AU (1) AU2011282549A1 (https=)
BR (1) BR112013002319A2 (https=)
CA (1) CA2806982A1 (https=)
CL (1) CL2013000308A1 (https=)
CO (1) CO6680670A2 (https=)
MX (1) MX2013001227A (https=)
NZ (1) NZ607306A (https=)
PH (1) PH12013500205A1 (https=)
RU (1) RU2013108394A (https=)
SG (1) SG187653A1 (https=)
TW (1) TW201210601A (https=)
WO (1) WO2012016109A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697458B2 (en) 2009-04-22 2014-04-15 Shat-R-Shield, Inc. Silicone coated light-emitting diode
US8883139B2 (en) * 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8741281B2 (en) * 2010-08-19 2014-06-03 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) * 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) * 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8900571B2 (en) * 2010-08-19 2014-12-02 Allergan, Inc. Compositions and soft tissue replacement methods
WO2012024072A1 (en) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition
US8926963B2 (en) * 2010-08-19 2015-01-06 Allergan, Inc. Compositions and soft tissue replacement methods
US8894992B2 (en) * 2010-08-19 2014-11-25 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) * 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US20120142684A1 (en) * 2010-12-02 2012-06-07 Allergan, Inc. Compounds and methods for skin repair
CA2890034A1 (en) * 2012-11-16 2014-05-22 Allergan, Inc. Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
US20140142092A1 (en) * 2012-11-16 2014-05-22 Allergan, Inc. Compounds and methods for skin repair
US9546162B2 (en) * 2013-09-27 2017-01-17 Allergan, Inc. Compounds and methods for skin repair
RU2625548C1 (ru) * 2015-04-29 2017-07-14 Жанна Юрьевна Юсова Способ коррекции возрастных изменений кожи лица
RU2663391C1 (ru) * 2018-01-30 2018-08-03 Игорь Николаевич Бондаренко Способ эстетической коррекции мягких тканей лица

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
US6586468B1 (en) * 1998-09-14 2003-07-01 Ono Pharmaceutical Co., Ltd. ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient
JP4618548B2 (ja) * 1999-11-24 2011-01-26 小野薬品工業株式会社 骨量低下疾患治療剤
NZ530885A (en) * 2001-07-23 2007-09-28 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having EP4 agonist as the active ingredient
US20040058313A1 (en) * 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
ES2584606T3 (es) * 2002-10-10 2016-09-28 Ono Pharmaceutical Co., Ltd. Microesferas que comprenden ONO-1301
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
JP5319065B2 (ja) * 2003-02-11 2013-10-16 アラーガン インコーポレイテッド 眼圧降下剤としての10,10−ジアルキルプロスタン酸誘導体
US20080234337A1 (en) * 2004-08-10 2008-09-25 Ono Pharmaceutical Co., Ltd. Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist
JP2006321737A (ja) * 2005-05-18 2006-11-30 Ono Pharmaceut Co Ltd Ep4アゴニストを含有する神経変性疾患の予防、治療および/または進展抑制剤
JP2007023028A (ja) * 2005-06-16 2007-02-01 Ono Pharmaceut Co Ltd 内耳疾患治療剤
US20070232660A1 (en) * 2006-04-04 2007-10-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
AU2007331471C1 (en) * 2006-12-15 2013-07-25 Glaxo Group Limited Benzamide derivatives as EP4 receptor agonists
EP2120962A1 (en) * 2006-12-18 2009-11-25 Allergan, Inc. Methods and compositions for treating gastrointestinal disorders
AU2008246579A1 (en) * 2007-05-08 2008-11-13 National University Corporation, Hamamatsu University School Of Medicine Cytotoxic T cell activator comprising EP4 agonist
GB0810615D0 (en) * 2008-06-10 2008-07-16 Glaxo Group Ltd Novel pharmaceutical

Similar Documents

Publication Publication Date Title
JP2013536183A5 (https=)
JP2013544842A5 (https=)
RU2013108394A (ru) Соединения и способы восстановления кожи
RU2013129262A (ru) Соединения и способы для восстановления кожи
JP2016538271A5 (https=)
BR112017020132A2 (pt) métodos para promover o crescimento capilar ou prevenir a perda de cabelo em um indivíduo e para preparar uma composição, e, composição
RU2014113663A (ru) Композиции кожного наполнителя для лечения мелких морщин
EA201792559A1 (ru) Фармацевтические композиции для местного применения
JP2017214429A5 (https=)
JPH11512438A (ja) 末梢性活性抗痛覚過敏オピエート
RU2012158142A (ru) Противоопухолевое средство, задействующее соединения с ингибирующим эффектом к киназам в комбинации
JP2019510034A5 (https=)
MX2020012336A (es) Formulacion farmaceutica.
PH12016501357A1 (en) Pharmaceutical preparation containing pyridylamino acetic acid compound
JP2019501879A5 (https=)
EP4410833A3 (en) Compositions and methods for treating fatty tissue buildup
JP2016510048A (ja) 毛髪処理の方法
CN1679480A (zh) 毛发化妆品
JP2015517567A (ja) デヒドロアビエチン酸を有効成分として含有する抗老化用組成物
RU2014112324A (ru) Применение органического соединения для лечения синдрома нунан
JP2015528479A5 (https=)
JP2016514150A5 (https=)
CN1679476A (zh) 毛发化妆品
RU2015154741A (ru) Ингибитор хориоретинальных нарушений
JP2015537028A5 (https=)